Tweets from GSK
-
#News for #Investors and #Media. Today we announced the completion of the acquisition of @Affinivax. This news follows our recent acquisition of @sierraoncology as we continue to focus on developing a strong portfolio of innovative vaccines and specialty medicines.
-
#News for #Investors and #Media. Today @Affinivax joins GSK. We look forward to collaborating with this new extended team to deliver a promising new vaccine technology. More at: gsk.to/3plDPXb
-
Alison, Head of Strategy, Planning and Campaigns, helps create impactful and timely campaigns to inform and educate audiences across our social media channels. Hear her story 👇 #AheadTogetherrT
-
We’re at @WLeish7 feeling inspired 💡 by the power of#sciencee to get ahead of#VisceralLeishmaniasiss, a Neglected Tropical Disease, which over 600 million people worldwide are at risk of acquiring.B
-
#News for #Investors and #Media on @ViiVHC's HPTN study presented at #AIDS2022 More at: gsk.to/3JaybAe
-
#News for #Investors and #Media on our commitment to voluntary licensing for populations with unmet needs in HIV. More at gsk.to/3voUvk6 #AIDS2022
-
Nearly 900,000 people die every year from complications due to #HepatitisB. At GSK, we are using science, technology and talent to get ahead of hepatitis together. We can’t wait for a world without #hepatitis. #Hepcantwait #WorldHepatitisDay
